Organic Science and Research Investment Act of 2025

What happened: On October 6, 2025, Rep. Vindman (D-VA) introduced HR5703, the Organic Science and Research Investment Act of 2025, in the 119th Congress. The bill was referred to the House Committee on Agriculture and subsequently to the Subcommittee on Conservation, Research, and Biotechnology on December 5, 2025. It remains in early legislative stages with no further action. The bill establishes a Coordinating and Expanding Organic Research Initiative within USDA to coordinate and expand organic agricultural research across multiple agencies, but it authorizes zero dollars for any activities. The money trail: This is an authorization bill that sets policy and creates a coordinating structure but does not allocate any actual funding. Authorization bills establish spending ceilings or policy frameworks, but actual money requires a separate appropriations bill. Since HR5703 authorizes $0, there is no funding mechanism to trace. Even if it were to pass, any future funding would require a separate appropriations process. Structural winners and losers: Because the bill authorizes no funding and is in early stages with minimal support, there are no identifiable winners or losers among publicly traded companies. The organic agriculture sector is not materially affected by a coordinating initiative with no budget. Companies like General Mills (GIS), Kellogg (K), and Danone (DAN) that have organic product lines would see no near-term revenue impact. Timeline: The bill has only 4 cosponsors and a junior sponsor, indicating low legislative momentum. It must pass through subcommittee, full committee, and both chambers, then be signed into law. Even if passed, it would require separate appropriations to have any operational effect. The companion bill S1385 in the Senate is also in early stages. No near-term market impact is expected.